儿童NHL-BFM组中暂定WHO实体:伴IRF4重排的大B细胞淋巴瘤与伴11q异常的伯基特样淋巴瘤的经验
该研究在德国NHL-BFM组儿童患者中筛查两种暂定WHO淋巴瘤实体。在滤泡性淋巴瘤和弥漫性大B细胞淋巴瘤中,7/34例(21%)显示IRF4断裂分离模式,并与I和II期疾病相关(P=0.043)。在形态学类似伯基特淋巴瘤的病例中,13/102例(13%)缺乏MYC断裂分离模式但FISH显示11q近端获得和端粒丢失。两种实体在NHL-BFM策略治疗下总生存率均为100%,可能成为未来临床试验中治疗降级的候选。
要点
- 儿童滤泡性淋巴瘤和DLBCL中21%(7/34)存在IRF4断裂分离,与I/II期相关(P=0.043)。
- 形态学类似伯基特淋巴瘤的病例中13%(13/102)缺乏MYC断裂但FISH显示11q获得/丢失。
- 伴11q获得-丢失模式的MYC阴性伯基特样淋巴瘤与无此模式的高级别B细胞淋巴瘤相比,年龄更大(P=0.004)、男性优势更少(P=0.003)、分期更低(P=0.040)、血清LDH更低(P=0.01)、腹部受累更少(P=0.008)。
核心结论
- 伴IRF4重排的大B细胞淋巴瘤和伴11q异常的伯基特样淋巴瘤在儿童NHL-BFM组中分别占相应筛查人群的21%(7/34)和13%(13/102),按NHL-BFM策略治疗总生存率均为100%,可能成为未来临床试验中治疗降级的候选。
研究设计与样本
- 在德国NHL-BFM组儿童患者(<18岁)中筛查两种暂定WHO实体,筛查人群包括滤泡性淋巴瘤和弥漫性大B细胞淋巴瘤(34例)以及形态学类似伯基特淋巴瘤、DLBCL和不可分类高级别B细胞淋巴瘤的病例(102例),采用荧光原位杂交(FISH)检测IRF4断裂分离、MYC断裂分离及11q近端获得和端粒丢失。
主要发现
- 在滤泡性淋巴瘤和DLBCL中,7/34例(21%)显示IRF4断裂分离模式,与I和II期疾病相关(P=0.043)。
- 在形态学类似伯基特淋巴瘤、DLBCL和不可分类高级别B细胞淋巴瘤的病例中,13/102例(13%)缺乏MYC断裂分离模式但FISH显示11q近端获得和端粒丢失。
- 伴11q获得-丢失模式的MYC阴性伯基特样淋巴瘤与无11q获得-丢失模式的高级别B细胞淋巴瘤相比,年龄更大(P=0.004)、男性优势更少(P=0.003)、分期更低(P=0.040)、血清LDH水平更低(P=0.01)、腹部受累更少(P=0.008)。
- 两种实体按NHL-BFM策略治疗总生存率均为100%。
关键数值与推荐
- 伴IRF4重排的大B细胞淋巴瘤在滤泡性淋巴瘤和DLBCL中占7/34例(21%),与I和II期疾病相关(P=0.043)。
- 伴11q异常的伯基特样淋巴瘤在形态学类似伯基特淋巴瘤、DLBCL和不可分类高级别B细胞淋巴瘤的病例中占13/102例(13%),FISH显示11q近端获得和端粒丢失。
- 伴11q获得-丢失模式的MYC阴性伯基特样淋巴瘤与无此模式的高级别B细胞淋巴瘤相比:年龄更大(P=0.004)、男性优势更少(P=0.003)、分期更低(P=0.040)、血清LDH水平更低(P=0.01)、腹部受累更少(P=0.008)。
临床怎么用
- 两种实体按NHL-BFM策略治疗总生存率均为100%,可能成为未来临床试验中治疗降级的候选。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Large B-cell lymphoma with IRF4 rearrangement, and Burkitt-like lymphoma with 11q aberration are two provisional lymphoma entities in the 2017 revision of the WHO classification of lymphoid neoplasms. Despite being more frequent in young patients, knowledge regarding their true incidence and clinical features in unselected cohorts of paediatric and adolescent patients is limited. We screened for both entities among paediatric patients (<18 years of age) in the German NHL-BFM (Non-Hodgkin lymphoma Berlin-Frankfurt-Münster) group. Among follicular lymphomas and diffuse large B-cell lymphomas (DLBCL), 7/34 cases (21%) showed an IRF4 break-apart pattern by fluorescence in situ hybridisation (FISH) and are associated with stages I and II disease (P = 0·043). Among lymphomas morphologically resembling Burkitt lymphoma, DLBCL and high-grade B-cell lymphoma, unclassifiable, 13/102 cases (13%) lacked a MYC break-apart pattern but were positive for 11q proximal gain and telomeric loss by FISH. MYC-negative Burkitt-like lymphomas with the typical 11q gain-loss pattern by FISH were older (P = 0·004), showed less male predominance (P = 0·003), lower stage (P = 0·040), lower serum LDH level (P = 0·01) and less abdominal involvement (P = 0·008) compared to high grade B-cell lymphomas without 11q gain-loss pattern. Both entities showed excellent outcome with overall survival of 100% when managed according to NHL-BFM strategies and may provide candidates for future therapy de-escalation in clinical trials.
引用
- Au-Yeung RKH, Arias Padilla L, Zimmermann M, et al. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. Br J Haematol. 2020. PMID: 32239695. doi:10.1111/bjh.16578
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。